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Abstract 
 
Aim: The aim of the present investigation was to evaluate clinically and 
radiographically the outcome of zirconia oral implants after 3 years in function. 
 
Materials and Methods: In 60 patients in need of either a single tooth replacement 
or a three-unit FDP a total of 71 one-piece zirconia implants were placed and 
immediately restored with temporary fixed prostheses. After a period of at least 2 
months in the mandible and at least 4 months in the maxilla, zirconia-based 
reconstructions were cemented. The implants were clinically and radiologically 
examined at implant insertion, prosthetic delivery, at 6 months and then yearly up to 
3 years. A linear mixed model was used to analyse statistically the influence of 
prognostic factors on changes in the marginal bone level. 
 
Results: 71 implants (48 in the mandible, 23 in the maxilla) inserted in 60 patients 
were restored with 49 crowns and 11 FDP. One patient lost his implant after 5 weeks. 
Five patients with 1 implant each could not be evaluated after 3 years. Based on 55 
patients with a total of 66 implants, the mean survival rate was 98.5% after 3 years in 
function. 
A statistically significant mean marginal bone loss (0.70 mm ± 0.72 mm) has been 
detected from implant insertion to the 3-year follow-up. The largest marginal bone 
loss occurred between implantation and prosthetic delivery (0.67 mm ± 0.56 mm). 
After delivery, no statistically significant bone level change was observed (0.02 mm ± 
0.59 mm). None of the investigated prognostic factors had a significant influence on 
changes in the marginal bone level. 
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Conclusions: After 3 years in function, the investigated one-piece zirconia implant 
showed a high survival rate and a low marginal bone loss. The implant system was 
successful for single tooth replacement and three-unit FDPs. Further investigations 
with long-term data are needed to confirm these findings. 
 
 
 4 
Introduction 
Endosseous screw-type implants offer a good opportunity to restore missing or lost 
teeth. Nowadays, there are a variety of different implant-systems and implants made 
of different materials available on the dental market. Regarding the material, 
implants from commercially pure titanium present the largest group of the used 
implants in the last decades. Based on various systematic reviews titanium implants 
reveal high implant survival and success rates over a long time period. Jung et al. 
(2012) reported in a systematic review a survival rate of 97.2% at 5 years and 95.2% 
at 10 years for commercially available titanium implants supporting single crowns 
(Jung et al. 2012). The reported survival rate of implants supporting FDPs was 
95.6% after 5 years and 93.1% after 10 years (Jung, Zembic, Pjetursson, Zwahlen, 
Thoma, 2012). 
However, there are a number of patients demanding for metal-free solutions for 
implants and prosthetics. In addition, a few preclinical studies showed that a certain 
amount of titanium could be found in the tissues around dental implants (Addison, et 
al., 2012; Bianco, Ducheyne, Cuckler, 1996). Moreover, there is some evidence that 
metals in the oral cavity undergo corrosion through an electrochemical redox 
reaction (Cadosch, et al., 2010) and may provoke hypersensitivity reactions (Jacobi-
Gresser, Huesker, Schutt, 2013) or even allergic reactions (Tschernitschek, 
Borchers, Geurtsen, 2005). Even though its estimated prevalence is low (0.6%), Ti 
allergy can be detected in dental implant patients (Sicilia, et al., 2008). 
In order to overcome these possible, unwelcomed reactions, zirconia implants have 
been investigated. They show a high biocompatibility, good physical characteristics 
and a tooth-like colour. In vitro evaluations confirmed that zirconia is not cytotoxic 
and is not able to generate mutations of the cellular genome (Covacci, et al., 1999). 
In vivo studies reported that the osseointegration of zirconia is similar to 
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commercially pure titanium (Kohal, Weng, Bachle, Strub, 2004; Manzano, Herrero, 
Montero, 2014) and histological investigations have shown that particularly in the 
early wound healing zirconia led to an increased proliferation of osteoblasts 
(Hisbergues, Vendeville, Vendeville, 2009). Based on the excellent mechanical 
properties in particular a high flexural strength (900-1200 MPa), high fracture 
toughness (7-10 MPa m½) and a fairly high hardness (1200 HV0.1) yttria-stabilized 
zirconia is an appropriate biomaterial for dental implants (Piconi, Maccauro, 1999).  
Zirconia has proven its value as a preferred esthetic material in challenging gingival 
conditions. Jung et al. (2007) have shown that all-ceramic abutments led to less 
change in color in a thin gingival biotype than titanium abutments (Jung, Sailer, 
Hammerle, Attin, Schmidlin, 2007). 
On the other hand, zirconia can show signs of aging under certain circumstances, 
which has been described as low temperature degradation (Kobayashi, Kuwajima, 
Masaki, 1981). Furthermore, one study showed that zirconium can also be found 
around zirconia implants (Cionca, Hashim, Meyer, Michalet, Mombelli, 2016). 
Whether or not this has an influence on the long-term outcomes of endosseous 
ceramic implants, remains to be clarified. Although ceramic implants are presently 
used for several indications, a recently published systematic review (Pieralli, Kohal, 
Jung, Vach, Spies, 2017) stated that few clinical reports on zirconia ceramic implants 
are available with an investigation time of three years and more. 
Therefore, the aim of the present investigation was to evaluate clinically and 
radiographically the long-term safety and efficiency of zirconia oral implants for 
single tooth replacement and three-unit fixed dental prostheses (FDPs) after 3 years 
in function. 
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Materials and Methods 
Study design 
The study was designed as a prospective cohort investigation according to Dekkers 
et al. (2012) (Dekkers, Egger, Altman, Vandenbroucke, 2012). It was performed at 
two investigation centers: at the Department of Prosthetic Dentistry, Center for 
Dental Medicine, Medical Center – University of Freiburg, Faculty of Medicine, 
Freiburg, Germany and at the Clinic of Fixed and Removable Prosthodontics and 
Dental Material Science, Center of Dental Medicine, University of Zurich, 
Switzerland. Both local ethical committees ((Ethics Commission, Medical Center – 
University of Freiburg, Freiburg (241/08) and (Ethic Committee of the Canton of 
Zurich (StV 08/10)) gave their approval and the study was conducted in full 
accordance with the World Medical Association Declaration of Helsinki. All patients 
were thoroughly informed about the study protocol and have signed an inform 
consent form prior to their inclusion. 
 
Participants 
Sixty patients in need of either exact one single tooth replacement or exact one 
implant supported three-unit fixed dental prosthesis were consecutively included. 
The detailed inclusion and exclusion criteria have been outlined already in a 
previous study (Jung, et al., 2016). In brief, the patients were only included if they 
were between 20 and 70 years old and in good general condition. The implant site 
had to be free of infection or extraction remnants and had to contain sufficient bone 
for the placement of an implant with a diameter of at least 4mm and a length of 
8mm. The patients were excluded if there were any general medical findings, which 
did not permit the surgical procedure. Further exclusion criteria were the intake of 
medication that is known to interfere with the objectives of the study, pregnancy, 
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signs of severe bruxism, a reported alcohol or drug abuse or nicotine abuse of more 
than 15 cigarettes per day. Also, the need for primary bone augmentation at the 
implantation site was an exclusion criterion; however, a simultaneous minor bone 
augmentation procedure was allowed to cover any exposed rough surfaces of the 
implant. 
 
Materials 
The presently investigated ceramic implant was a commercially available one-piece 
zirconia screw-type implant (ceramic.implant; vitaclinical, VITA Zahnfabrik, Bad 
Säckingen, Germany). The endosseous part is constructed in a cylindric-conical 
geometrical form. The available implant lengths were 8, 10, 12 and 14 mm and the 
available diameters 4.0, 4.5 and 5.5 mm. 
Regarding the material composition, surface roughness and processing steps, please 
refer to Fischer et al. (2016) (Fischer, Schott, Martin, 2016). 
Interventions 
A late implant insertion (3 months after tooth extraction) was recommended; under 
optimal circumstances a delayed implant insertion (6-8 weeks after extraction) was 
possible (Fig. 1a). For the placement of the implants, a mucoperiostal flap was 
raised as far as necessary under local anesthesia (UbistesinTM forte) (Fig. 1b). The 
implants were placed according to the manufacture’s recommendations in a 
prosthetically correct position and angulation (Fig. 1c). If required, guided bone 
regeneration was performed with xenogenic bone substitutes (BioOssâ Spongiosa 
Granules, particle size 0.25–1.0 mm; Geistlich Pharma AG, Wolhusen, Switzerland) 
(Fig. 1d) and a collagen membrane (BioGideâ Membrane; Geistlich Pharma AG) to 
cover the rough implant surface or to compensate deficiencies in the bony contour 
 8 
(Fig. 1e). The flap was sutured for a transmucosal healing and the implants were 
immediately restored with prefabricated provisional reconstructions made from 
PMMA (Fig. 1f). The occlusion and lateral articulation was carefully checked and 
adjusted, i.e. contacts in static or dynamic occlusion were removed.  
 
Postoperative treatment 
Patients were instructed to not mechanically clean the operation field but to rinse 
twice a day with 0.2% chlorhexidine aqueous solution. They were given antibiotic 
prophylaxis on the day of surgery and thereafter three times a day for 5 days (750mg 
Clamoxyl® in Zurich; 300mg clindamycin in Freiburg) after implant placement. 
Analgetics (500 mg Mefenacid in Zurich; 400 mg Ibuprofen in Freiburg) were 
dispensed and taken according to the individual requirements. Sutures were 
removed 10 days after the surgical intervention. 
 
Prosthetic insertion and follow-ups 
The final prosthetic restoration was inserted at the earliest 2 months after implant 
placement in the mandible and 4 months in the maxilla. Both types of restorations, 
the implant supported SC and the implant supported three unit FDPs were 
manufactured from a zirconia framework (VITA In-Ceram YZ), which was 
subsequently veneered (VITA VM9) and adhesively cemented with a dual-curing 
cement (RelyX Unicem Aplicap; 3M Espe) (Spies, Kohal, Balmer, Vach, Jung, 2017) 
(Fig. 1g).  
The implants were examined at baseline (implant insertion), at the placement of the 
restoration, at 6 months and then yearly up to 3 years (Fig.2a-c). 
 
Analyses 
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Clinical and radiographic examination  
At each visit, soft tissue parameters in terms of Probing depth (PD), Marginal soft 
tissue level (ML), Clinical attachment level (CAL), Plaque control record (Pcr) and 
Bleeding on probing (BoP) were recorded at 4 positions of the implants and 
neighboring teeth. One examiner per investigation center performed the 
measurements. Examiner alignment and calibration have been performed prior to 
the examinations. PD, ML, CAL and the presence of Plaque were recorded with a 
periodontal probe (PCP 12 Hu Friedy, Rotterdam, Netherlands) and the reference 
for the assessment of CAL und ML was the margin of the implant-crown / cemento-
enamel junction.  For the analyses of PD, ML and CAL the four implant- / tooth-sites 
(mesial, buccal, distal lingual) were averaged. The size of the gingival papilla (Index 
according to Jemt (Jemt, 1997)) was recorded between the implants and 
neighboring teeth.  
Standardized periapical radiographs were taken at implant insertion, at the 
placement of the restoration, at 1 year and at 3 years with an individual acrylic 
radiographic film holder (Fig 3a-d and 4a-d). Radiographs were imported in an open 
source image-processing program (ImageJ, National Institutes of Health, 
Bethesda, USA) and calibrated to measure the peri-implant bone level at each 
timepoint. Marginal bone loss was calculated as difference between baseline 
(implant placement) and subsequent follow-ups. 
During the evaluation of the radiographic outcome at the 3-year follow-up, the 
authors detected a calibration error (incorrect distance of implant threads) for the 
measurements up to the 1-year follow-up. This previously published data of the 
same cohort (Jung, et al., 2016) were recalculated and subsequently corrected for 
the present publication. 
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Statistical analysis 
The statistical analysis was performed at the University of Freiburg, Center for 
Medical Biometry and Medical Informatics, Institute for Medical biometry and 
Statistics, Freiburg, Germany. 
 
Sample size calculation has been performed as previously described in detail (Jung, 
et al., 2016). For the analysis of the mean marginal bone level linear mixed models 
with random intercept were used to take within-subject dependencies (i.e. 2 implants 
within 1 patient) into account. For the clinical parameters Wilcoxon signed-rank tests 
were used to compare both results of implants and corresponding teeth per time 
point and results between 0 and 36 months within implants and teeth, respectively. 
The calculations were performed with the statistical software STATA 14.2 (StataCorp 
LT, College Station, TX, USA). The probability level for statistical significance was set 
to p < 0.05. 
 
Results 
Patient demographics and baseline characteristics 
Pretreatment examination was performed at 63 patients at one of the two 
investigation centers. Three patients had at least one violation of inclusion/exclusion 
criteria and were therefore excluded from the analysis. Two of these three patients 
received more than exactly one single tooth replacement and in one patient no 
implant could be placed due to insufficient bone volume. 
The remaining 60 patients (30 male / 30 female) had a mean age of 48.1 years ± 
13.0 at the pretreatment examinations. They received a total of 71 implants (23 in 
the upper jaw / 48 in the lower jaw) (Table 1 and 2) between November 2009 and 
April 2011. Five implants in the maxilla and 6 in the mandible were placed with a 
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simultaneous guided bone augmentation procedure. Since one patient lost his 
implant 5 weeks after implantation due to a missing osseointegration, the implants 
were restored with 48 SC and 11 FDPs. 
At the 3-year follow-up after final prosthetic restoration, 54 patients with a total of 65 
implants could be evaluated. Five patients with one implant each did not show up for 
different reasons (one moved away; one missed the appointment; three more 
patients refused further participation). As described above, one patient with one 
implant dropped out short time after implant placement. 
 
Analysis of the marginal bone loss (primary endpoint)  
The mean marginal bone loss from implant insertion to the 3-year follow-up after the 
final prosthetic restoration was 0.70 mm ± 0.72 mm. Table 3 shows the marginal 
bone loss from baseline to each evaluated timepoint. The change of mean marginal 
bone level was statistically significant (p<0.001) between implantation and the 3-year 
follow-up. The largest marginal bone loss occurred between implantation and the 
insertion of the final restoration (0.67 mm ± 0.56 mm). From delivery of the 
restorations to the 3-year follow-up, no further statistically significant bone loss was 
observed (0.02 mm ± 0.59 mm; p = 0.66). 
The frequency distribution for mean marginal bone level changes was as follows: 
13% of the implants gained marginal bone, while 56% lost less than 1 mm, 22% 1 
mm to 1.5 mm, 6% 1.5 mm to 2 mm and 3% more than 2 mm of marginal bone. 
None of the investigated prognostic factors (center, jaw, type of reconstruction, 
implant diameter and length) had a significant influence on changes in the marginal 
bone level, except the baseline value of mean initial insertion depth of the implants 
(p<0.001) (Table 4).  
The estimator for “insertion depth” indicates, that a change in insertion depth at 
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implantation of 1 mm leads to a change of 0.695 mm marginal bone loss after 3 
years. The estimated difference in mean marginal bone loss is about a value of 0.152 
larger for Zurich than for Freiburg, about 0.390 units smaller for the upper jaw than 
for the lower jaw and 0.326 units smaller for a bridge than for a single tooth. For an 
implant diameter of 4.5 and 5.5 mm the difference is about 0.065 and 0.275 units 
larger than for diameter 4.0 mm, respectively. For an implant length of 10 mm the 
difference is about 0.156 units smaller and for an implant length of 12 and 14 mm 
about 0.226 and 0.282 units larger than for length of 8 mm, respectively.  
 
Analysis of secondary endpoint (survival rate of the implants) 
During the observation time, one implant in the mandible failed 5 weeks after 
insertion. In addition, 5 implants in different patients could not be evaluated because 
the patients did not show up to the 3-year follow-up. Based on 55 patients with a total 
of 66 implants, the mean survival rate was 98.5% (95% CI: 91.8% - 99.9%) after 3 
years in function. 
Clinical measurements 
At each visit, plaque frequency was recorded at 4 sites of the implants and adjacent 
teeth (Table 5). At prosthetic insertion the frequencies of plaque around implants 
(11.8%) and teeth (21.0%) was at the lowest level. This value increased for both 
groups between prosthetic insertion and the 6-month follow-up and remained on a 
relatively high level up to the 3-year follow-up (implants: 20.8%, teeth 41.4%). At 
each timepoint plaque frequencies were significantly lower at implant sites compared 
to teeth. 
At implant sites, the mean Probing depth (Table 6) increased from 2.71 mm at 
prosthetic delivery to 3.52 mm after 3 years. Wilcoxon signed-rank test applied to the 
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differences comparing 36 months with baseline showed significant changes in PD on 
patient level for implants (p<0.001) but not for teeth. The mean PD at the adjacent 
teeth changed only from 2.53 mm to 2.54 mm during the observation period. The 
difference at each follow-up between implants and teeth was statistically significant 
(p<0.0001). 
The frequency of Bleeding on probing (BoP) (Table 7) was significantly higher during 
the whole observation time for implants compared to the neighboring teeth except at 
prosthetic insertion. The largest increase could be observed between prosthetic 
delivery and the 6-month follow-up for both groups. After 3 years, BOP for implants 
was 40.8%, which is about 2 times higher than for teeth (23.2%). 
Mean marginal soft tissue level (Table 8) decreased from 0.7 mm to 0.65 mm at 
implants. At adjacent teeth there was nearly no change in mean marginal soft tissue 
level (0.01mm), but the Wilcoxon signed-rank test (baseline vs 36 month) showed 
significant changes in ML on patient level (p=0.047). 
The Clinical attachment level (CAL) (Table 9) around the implants at prosthetic 
insertion was 2.76 mm and 3.14 mm at the teeth. Until the 3-year follow-up, changes 
per patient in CAL were not significant at implant sites (p=0.523) and around teeth 
(p=0.052).  
 
Discussion 
The present multicenter prospective cohort investigations evaluated the mean 
marginal bone loss, survival rate and peri-implant soft tissue conditions of 71 
zirconia implants placed in 60 healthy patients after 3 years in function. Presently, 
only few clinical reports on zirconia ceramic implants are available with an 
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investigation time of three years and more (Pieralli, et al., 2017). Therefore, the 
present investigation adds to the scientific knowledge regarding these implants. 
Long-term stable conditions of osseointegration around implants particularly in 
respect to marginal bone loss have been identified as success criteria for longevity 
for implants (Albrektsson, Zarb, Worthington, Eriksson, 1986; Roos, et al., 1997). 
The present investigation showed a mean marginal bone loss of 0.70 mm after 3 
years with the maximum loss between the interval of implantation and prosthetic 
delivery (0.67 mm).    
Another recently published prospective clinical trial with a similar study design 
(Spies, Balmer, Patzelt, Vach, Kohal, 2015) investigated 53 immediately temporized 
one-piece alumina-toughened zirconia implants over an observation time of 3 years 
after prosthetic delivery. The authors reported a similar mean marginal bone loss 
over the 3 years. As in the present study, they observed the greatest amount of bone 
loss between implantation and prosthetic insertion (0.70 mm): No further statistically 
significant bone loss up to the 3-year follow-up (0.79 mm) occurred. The finding of a 
pronounced MBL in the first 6 months after implant placement is in line with another 
study reporting on marginal bone loss over time for zirconia implants up to 4 years 
(Borgonovo, et al., 2013). 
In a recently published systematic review (Pieralli, et al., 2017), the authors stated 
that no further meta-analysis for MBL of zirconia implants except for 12 months data 
could be performed due to the lack of long-term data. Their analysis after 12 months 
resulted in a MBL of 0.79 mm, which is slightly larger as observed in the present 
study (0.60 mm). However, other clinical studies analyzing MBL around zirconia 
implants reported results after 3 years of 0.13 mm (Brull, van Winkelhoff, Cune, 
2014) and 0.79 mm (Spies, et al., 2015), of 1.63 mm after 4 years (Borgonovo, et al., 
2013) and of 1.23 mm after 5 years (Grassi, et al., 2015). Considering the fact that 
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after an initial remodeling, no further significant marginal bone loss could be 
detected and based on MBL after 3 years in this present study it can be concluded 
that marginal bone level around zirconia implants might be stable over a longer 
period of time.  
Although in the present investigation the mean marginal bone loss amounted only to 
0.70 mm, it has to be revealed that 2 out of 65 implants had a MBL ≥ 2 mm and 4 
implants showed a MBL between 1.5 and 2 mm. 
In the present investigation none of the evaluated prognostic factors (center, jaw, 
type of reconstruction, implant diameter and length) had a significant influence on 
MBL except for the baseline value insertion depth. The small p-value (p<0.001) for 
marginal bone level at implantation in the mixed effect model should be interpreted 
cautiously. In this change from baseline analysis, the baseline value was only 
considered for adjustment according to EMA guidance “Points to consider on 
Adjustment for Baseline Covariates” (European Agency for the Evaluation of Medical 
Products, CPMP/EWP/2863/99)."   
One implant out of 71 failed in our investigation 5 weeks after implantation due to a 
loss of osseointegration. Since 3 implants couldn’t be evaluated at the 1-year follow-
up and 5 at the 3-year follow-up, the survival rate was 98.6% after 1 year and 98.5% 
after 3 years, respectively. In a recently published systematic review (Hashim, 
Cionca, Courvoisier, Mombelli, 2016), the one-year overall survival rate of (one- and 
two-piece) zirconia implants was calculated with 92% (95% CI: 87% - 95%). Due to 
the limited observation periods of the included studies, no meta-analysis could be 
performed for later timepoints. The authors also reported a tendency towards early 
failure of one-piece implants with a calculated early failure rate at 77% (95% CI: 56% 
- 90%). However, no further loss of implants could be detected up to the 3-year 
follow-up. 
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At each follow up, soft tissue parameters were recorded of the implants and 
neighboring teeth. Bleeding on probing was significantly more frequent after 
prosthetic delivery over the whole observation time for implants in comparison to 
teeth, although the plaque frequency was significantly lower at implant sites 
compared to teeth. As described in the literature, BOP is considered a clinical key 
measure to distinguish between disease and peri-implant health (Jepsen, et al., 
2015) and is always present with peri-implant disease (Zitzmann, Berglundh, 2008). 
Nevertheless,	peri-implantitis is characterized by changes in the marginal bone level 
in conjunction with Bleeding on probing with or without concomitant deepening of 
Probing depth (Lang, Berglundh, Working Group 4 of Seventh European Workshop 
on, 2011). In this study no significant changes in marginal bone level could be found 
after delivery of the restorations. However, the analyses showed significant changes 
in PD (p<0.001) on patient level and an increase in mean PD at implant sites but not 
for teeth.  
Interestingly, the analysis for CAL at implant sites demonstrated no significant 
differences to baseline after 3 years although PD increased over time and ML 
remained stable. A possible reason behind this is that PD, ML and CAL have been 
measured individually. CAL was not calculated as the mathematically sum of PD and 
ML which could lead to a small discrepancy to the measured value. However the 
Clinical attachment level did not change significantly over the 3 years, neither for 
implants nor for teeth, indicating stable soft tissue conditions around the investigated 
implants. 
The present study was designed as a prospective cohort investigation without a 
control group. This might be a major limitation of the study and does not allow a 
direct comparison within the same cohort to titanium implants. However, it allowed 
us to collect more data and to gain clinical experience with a rather new implant 
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material. An affirmative factor is, that the study was performed in two investigational 
centers, which reduces the center effect on the results. 
In addition, 11 out of 71 implants of the present study were placed with a 
simultaneous bone augmentation procedure using a xenogenic bone substitute. This 
can be another limitation of the present study because bovine bone substitute shows 
a radiopacity similar to human bone. It is therefore often difficult to distinguish from 
pristine bone and could have had an influence on the radiographical measurements. 
To ensure a standardized analysis of the periimplant bone loss, we measured the 
highest bone-to-implant-contact without differentiating between human bone and 
substitute. 
 
In conclusion, the investigated one-piece zirconia implant showed a high survival rate 
and a low marginal bone loss after 3 years in function. Therefore, the implant can be 
regarded as successful for single tooth replacement and three-unit FDPs. 
Nevertheless, further investigations with long-term data are still needed to confirm 
these positive findings. 
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Figure legends 
Fig. 1  Implant insertion and prosthetic delivery: 
a)  initial Situation  
 18 
b)  mucoperiostal flap  
c)  implant insertion 
d)  guided bone regeneration 
e)  collagen membrane 
f)  immediate provisional reconstruction 
g)  prosthetic delivery 
Fig 2  Follow-ups: 
a)  1 year in function 
b)  2 years in function 
c)  3 years in function 
Fig. 3a-d  Radiographic image (SC):   
(a) after implantation and provisional reconstruction 
(b) at prosthetic delivery 
(c) after 1 year in function 
(d) after 3 year in function  
Fig. 4 a-d Radiographic image (FDP):   
(a) after implantation and provisional reconstruction 
(b) at prosthetic delivery 
(c) after 1 year in function 
(d) after 3 year in function  
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Tables  	Table	1:	Implant	distribution		
FDI 17 16 15 14 13 12 11 21 22 23 24 25 26 27  Total 
Upper Jaw 1 1 4 5 1 0 1 0 0 0 2 5 3 0  23 
Lower Jaw 4 11 4     1   2 7 13 6  48 
FDI 47 46 45 44 43 42 41 31 32 33 34 35 36 37  71 	Table	2:	Implant	characteristics		 	 implant	diameter	 implant	length	4.0	 4.5	 5.5	 8	 10	 12	 14	Upper	Jaw	 11	 11	 1	 6	 8	 8	 1	Lower	Jaw	 15	 21	 12	 6	 31	 11	 0	
Total	 26	 32	 13	 12	 39	 19	 1		Table	3:	Marginal	bone	loss	from	baseline	(implant	placement)	to	all	evaluated	timepoints			 Marginal	bone	loss	at	prosthetic	delivery	Treatment	 Total	 Missing	 Total	valid	 Mean	 Std	 Min.	 1.	Quartile	 Median	 3.	Quartile	 Max	SC	 49	 2	 47	 0.739	 0.606	 -0.41	 0.34	 0.64	 1.09	 2.78	FDP	 22	 1	 21	 0.534	 0.425	 -0.11	 0.11	 0.56	 0.86	 1.43	
Total	 71	 3	 68	 0.676	 0.561	 -0.41	 0.32	 0.60	 0.96	 2.78		 Marginal	bone	loss	at	1	year	follow-up	Treatment	 Total	 Missing	 Total	valid	 Mean	 Std	 Min.	 1.	Quartile	 Median	 3.	Quartile	 Max	SC	 49	 3	 46	 0.668	 0.613	 -0.45	 0.19	 0.58	 1.01	 2.33	FDP	 22	 3	 19	 0.438	 0.425	 -0.11	 0.04	 0.38	 0.83	 1.39	
Total	 71	 6	 65	 0.601	 0.571	 -0.45	 0.15	 0.53	 0.86	 2.33		 Marginal	bone	loss	at	3	year	follow-up	Treatment	 Total	 Missing	 Total	valid	 Mean	 Std	 Min.	 1.	Quartile	 Median	 3.	Quartile	 Max	SC	 49	 6	 43	 0.734	 0.772	 -0.44	 0.18	 0.55	 1.09	 3.21	FDP	 22	 1	 21	 0.638	 0.616	 -0.56	 0.35	 0.60	 1.13	 1.75	
Total	 71	 7	 64	 0.702	 0.721	 -0.56	 0.26	 0.59	 1.11	 3.21										
			Table	4:	Investigated	prognostics	factors	on	marginal	bone	loss		
Variable  estimate 95% CI  p- value  
Marginal bone level at implantation  -0.695 [-1.034, -0.356]  <0.001  
center (Zurich/Freiburg) 0.152 [-0.236, 0.541]  0.441 
jaw (maxilla/mandible) -0.390 [-0.804, 0.024]  0.065 
SC / FDP -0.326 [-0.818, 0.165]  0.193 
Implant diameter 4.5 relativ to 4.0  0.065 [-0.195, 0.325]  
0.450 
Implant diameter 5.5 relativ to 4.0  0.275 [-0.153, 0.703]  
Implant length 10 relativ to 8  -0.156 [-0.474, 0.160]  
0.064 Implant length 12 relativ to 8  0.226 [-0.183, 0.635]  
Implant length 14 relativ to 8  0.282 [-0.994, 1.559]  		Table	5:	Comparison	of	the	Plaque	frequency	at	implants	and	adjacent	teeth	(Δ	shows	the	mean	difference	to	baseline	(0	month)	in	patients	with	both	measurements.	The	p-values	at	the	bottom	refer	to	a	Wilcoxon	signed-rank	test	applied	to	the	differences	comparing	36	months	with	baseline)				 Total	valid	 Plaque	in	%	 Signed-rank	Implants	 Δ	 Teeth	 Δ	0	month	 63	 11.8±25.8	 		 21.0±25.5	 	 p=	0.0025	6	months	 62	 22.1±30.8	 10.1	 37.5±32.9	 16.1	 p<0.0001	12	months	 61	 21.6±29.8	 0.9	 41.6±32.6	 19.9	 p<0.0001	24	months	 60	 20.1±27.9	 7.8	 47.3±30.5	 25.2	 p<0.0001	36	months	 57	 20.8±26.7	 8.5	 41.4±29.3	 19.3	 p<0.0001	Signed-rank	test	(0	vs.	36)	 		 		 p=	0.022	 		 p<0.0001	 		 	 	 	 	 	 								
Table	6:	Comparison	of	the	mean	Probing	depth	around	implants	and	adjacent	teeth	(Δ	shows	the	mean	difference	to	baseline	(0	month)	in	patients	with	both	measurements.	The	p-values	at	the	bottom	refer	to	a	Wilcoxon	signed-rank	test	applied	to	the	differences	comparing	36	months	with	baseline)				 Total	valid	 PD	in	mm	 Signed-rank	test	Implants	 Δ	 Teeth	 Δ	0	month	 63	 2.71±0.62	 	 2.53±0.44	 	 p=	0.111	6	months	 62	 3.24±0.59	 0.56	 2.46±0.48	 -0.06	 p<0.0001	12	months	 61	 3.47±0.67	 0.78	 2.43±0.52	 -0.10	 p<0.0001	24	months	 60	 3.60±0.66	 0.89	 2.46±0.45	 -0.06	 p<0.0001	36	months	 57	 3.52±0.66	 0.81	 2.54±0.57	 0.02	 p<0.0001	Signed-rank	test	(0	vs.	36)	 	 		 p<0.0001	 		 p=0.80	 		 	 	 	 	 	 						Table	7:	Comparison	of	Bleeding	on	probing	frequency	at	implants	and	adjacent	teeth	(Δ	shows	the	mean	difference	to	baseline	(0	month)	in	patients	with	both	measurements.	The	p-values	at	the	bottom	refer	to	a	Wilcoxon	signed-rank	test	applied	to	the	differences	comparing	36	months	with	baseline)			 	 Total	valid	 BoP	%	 Signed-rank	test	Implants	 Δ	 Teeth	 Δ	0	month	 63	 16.8±27.5	 	 13.5±21.9	 	 p=	0.909	6	months	 62	 43.5±36.5	 26.4	 29.4±42.8	 16.1	 p=0.0052	12	months	 61	 57.5±-32.9	 41.8	 34.0±48.9	 20.5	 p=0.0001	24	months	 60	 48.9±36.3	 31.7	 30.8±38.9	 17.1	 p=0.0013	36	months	 57	 40.8±32.9	 23.5	 23.2±33.0	 9.6	 p=0.0045	Signed-rank	test	(0	vs.	36)	 	 		 p<0.0001	 		 p=0.137	 		 	 	 	 	 	 													
	Table	8:	Mean	Marginal	soft	tissue	level	at	implant	and	adjacent	teeth	sites.		(Δ	shows	the	mean	difference	to	baseline	(0	month)	in	patients	with	both	measurements.	The	p-values	at	the	bottom	refer	to	a	Wilcoxon	signed-rank	test	applied	to	the	differences	comparing	36	months	with	baseline)			 Total		valid	 Marginal	soft	tissue	level	in	mm	Implants	 Δ			 Teeth	 Δ			0	month	 63	 0.70±0.33	 	 1.22±0.80	 	6	months	 62	 0.70±0.48	 -0.020	 1.16±0.77	 -0.071	12	months	 61	 0.71±0.24	 0	 1.22±0.72	 -0.029	24	months	 60	 0.66±0.27	 -0.033	 1.23±0.67	 0.004	36	months	 57	 0.65±0.27	 -0.025	 1.21±0.59	 0.057	Signed-rank	test	(0	vs.	36)	 	 		 p=0.526	 		 p=0.047		 	 	 	 	 			Table	9:	Mean	Clinical	attachment	level	around	implants	and	adjacent	teeth.	(Δ	shows	the	mean	difference	to	baseline	(0	month)	in	patients	with	both	measurements.	The	p-values	at	the	bottom	refer	to	a	Wilcoxon	signed-rank	test	applied	to	the	differences	comparing	36	months	with	baseline)					 Total	Valid	 CAL	in	mm	Implants	 Δ	 Teeth	 Δ	0	month	 63	 2.76+-0.68	 	 3.14+-0.85	 	6	months	 62	 2.88+-0.96	 0.139	 3.08+-0.85	 -0.077	12	months	 61	 3.05+-0.92	 0.258	 3.11+-0.82	 -0.053	24	months	 60	 2.81+-1.09	 -0.029	 3.15+-0.75	 0.002	36	months	 57	 2.78+-1.00	 -0.029	 3.19+-0.74	 0.118	Signed-rank	test	(0	vs.	36)	 	 		 p=0.523	 		 p=0.052		 	 	 	 	 				
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